MANCIA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 94.042
AS - Asia 52.333
EU - Europa 39.676
SA - Sud America 8.433
AF - Africa 840
Continente sconosciuto - Info sul continente non disponibili 102
OC - Oceania 99
AN - Antartide 1
Totale 195.526
Nazione #
US - Stati Uniti d'America 92.013
SG - Singapore 19.404
CN - Cina 12.819
HK - Hong Kong 10.832
RU - Federazione Russa 8.764
BR - Brasile 6.829
SE - Svezia 5.534
DE - Germania 5.419
IE - Irlanda 5.325
VN - Vietnam 4.667
IT - Italia 4.524
UA - Ucraina 3.624
GB - Regno Unito 2.180
CA - Canada 1.448
KR - Corea 1.144
FI - Finlandia 997
FR - Francia 834
IN - India 767
AR - Argentina 644
AT - Austria 641
TR - Turchia 420
BD - Bangladesh 381
NL - Olanda 372
MX - Messico 362
ID - Indonesia 328
ZA - Sudafrica 326
JP - Giappone 282
EC - Ecuador 279
PL - Polonia 263
IQ - Iraq 247
DK - Danimarca 199
BE - Belgio 165
ES - Italia 164
CO - Colombia 151
VE - Venezuela 130
PY - Paraguay 129
CZ - Repubblica Ceca 119
PK - Pakistan 114
SA - Arabia Saudita 98
UZ - Uzbekistan 98
PE - Perù 95
MA - Marocco 92
AE - Emirati Arabi Uniti 91
CL - Cile 91
IR - Iran 88
KE - Kenya 85
AU - Australia 79
EG - Egitto 78
EU - Europa 75
TN - Tunisia 67
CH - Svizzera 61
GR - Grecia 61
MY - Malesia 58
RO - Romania 57
UY - Uruguay 56
PT - Portogallo 54
IL - Israele 47
LT - Lituania 47
KZ - Kazakistan 46
AZ - Azerbaigian 44
BG - Bulgaria 43
TW - Taiwan 43
JO - Giordania 40
DO - Repubblica Dominicana 39
JM - Giamaica 39
NP - Nepal 37
DZ - Algeria 34
PH - Filippine 34
TT - Trinidad e Tobago 31
ET - Etiopia 28
AL - Albania 27
RS - Serbia 24
NG - Nigeria 23
PA - Panama 22
BO - Bolivia 21
TH - Thailandia 21
HU - Ungheria 20
OM - Oman 20
SN - Senegal 20
LV - Lettonia 19
NZ - Nuova Zelanda 19
PS - Palestinian Territory 19
SK - Slovacchia (Repubblica Slovacca) 19
CR - Costa Rica 18
MK - Macedonia 18
NO - Norvegia 18
BB - Barbados 17
HN - Honduras 17
LB - Libano 17
LK - Sri Lanka 17
AM - Armenia 16
BY - Bielorussia 16
MU - Mauritius 16
BH - Bahrain 15
BA - Bosnia-Erzegovina 14
XK - ???statistics.table.value.countryCode.XK??? 14
GE - Georgia 13
A2 - ???statistics.table.value.countryCode.A2??? 12
MD - Moldavia 12
AO - Angola 11
Totale 195.311
Città #
Ann Arbor 13.088
Singapore 11.064
Hong Kong 10.784
Woodbridge 8.061
Fairfield 7.989
Ashburn 6.512
Houston 5.702
Dublin 5.087
Chandler 4.641
Jacksonville 3.872
Wilmington 3.446
Frankfurt am Main 3.250
Seattle 3.123
New York 2.738
Dearborn 2.672
Cambridge 2.610
Hefei 2.426
Princeton 2.039
Santa Clara 1.935
Beijing 1.752
Dallas 1.420
Ho Chi Minh City 1.405
Milan 1.333
Los Angeles 1.263
Seoul 1.095
Lawrence 967
Nanjing 956
Altamura 954
Hanoi 922
Moscow 851
Chicago 734
Shanghai 685
The Dalles 678
Buffalo 657
São Paulo 644
San Diego 597
Lachine 580
Vienna 497
Hangzhou 494
Guangzhou 386
Dong Ket 356
Boardman 352
Andover 320
Nanchang 315
Council Bluffs 310
Munich 306
Shenyang 296
Toronto 291
Ottawa 276
Salt Lake City 275
Hebei 260
Helsinki 258
London 254
Falls Church 243
Changsha 232
Tianjin 232
Rio de Janeiro 216
Jiaxing 188
Norwalk 186
Nuremberg 183
Tokyo 178
Warsaw 168
Columbus 157
Jakarta 146
Jinan 143
Brussels 139
Haiphong 139
Elk Grove Village 138
Da Nang 135
Belo Horizonte 131
Brooklyn 130
Fremont 130
Rome 130
Zhengzhou 128
Brasília 127
Mountain View 121
Johannesburg 117
Montreal 115
Philadelphia 114
Phoenix 112
Stockholm 109
Tampa 109
Curitiba 106
Kunming 106
San Francisco 103
Huizen 99
Lissone 93
Porto Alegre 93
Atlanta 92
Quito 92
Turku 91
Biên Hòa 90
Chennai 89
Guayaquil 89
Mexico City 88
Tashkent 86
Denver 83
Boston 82
Detroit 82
Mumbai 81
Totale 129.819
Nome #
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 813
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 590
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 576
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 430
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology? 409
Relationship between arterial distensibility and coronary atherosclerosis in angina patients 405
Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation 400
Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study 395
Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation 394
Erratum: Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study [High Blood Press Cardiovasc Prev, DOI 10.1007/s40292-015-0121-4] 392
The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study 385
Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys 379
Heart rate as a sympathetic marker during acute adrenergic challenge 377
Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation 363
Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals 355
Persistence of arterial functional abnormalities after successful coronary revascularization 352
Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity 350
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 349
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age 341
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 337
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 337
Studio della distensibilita arteriosa nell'uomo. Quali i meccanismi di modulazione, come varia in condizioni patologiche ed effetto della terapia [Study of arterial distensibility in man. Modulating mechanisms, pathological conditions and effects of treatment] 334
Calcium antagonists and neural control of circulation in essential hypertension 331
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 324
Early alterations in left ventricular diastolic function in normotensive diabetic patients 323
Early cardiac and vascular structural changes in subjects with parental hypertension 319
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 317
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 315
European society of hypertension guidelines for blood pressure monitoring at home: A summary report of the second international consensus conference on home blood pressure monitoring 308
Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy 307
External adjustment for unmeasured confounders improved drug-outcome association estimates based on health care utilization data 306
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 304
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension 303
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 303
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 302
Differing associations for sport versus occupational physical activity and cardiovascular risk 300
Changes in 24 hour blood pressure and in cardiac and vascular structure in normotensive subjects with parental hypertension 299
Women discontinue antihypertensive drug therapy more than men. Evidence from an Italian population-based study 297
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 295
Long-term exposure to antihypertensive drugs and the risk of cancer occurrence: evidence from a large population-based study 294
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 294
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 293
2013 ESH/ESC practice guidelines for the management of arterial hypertension 293
Cardiopulmonary receptor regulation of renin release 292
Statins and the risk of diabetes: Evidence from a large population-based cohort study 287
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 287
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 285
Home blood pressure telemonitoring improves hypertension control in general practice. the TeleBPCare study 285
Better compliance to antihypertensive medications reduces cardiovascular risk 284
Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. 284
Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between 2005 and 2009 283
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period. 279
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 279
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 276
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 274
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 274
High-altitude exposure of three weeks duration increases lung diffusing capacity in humans 274
Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors 273
Acute effect of high-fat meal on endothelial function in moderately dyslipidemic subjects 272
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 272
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans 271
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 270
8c.04: Possible role of arterial function in cancer treatment targeting vascular endothelial growth factor receptor oncologic response 270
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 270
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 269
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 269
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 266
Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class 266
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 266
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 266
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 264
Different effects of antihypertensive treatment on office and ambulatory blood pressure: Ameta-analysis 264
Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments 263
The Pamela study: main findings and perspectives 263
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 263
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 262
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 262
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 262
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 261
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 259
Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude 258
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 258
Fluctuations of radial artery distensibility throughout the menstrual cycle 257
Early impairment of large artery structure and function in Type I diabetes mellitus 257
Increased arterial stiffness in normoglycemic normotensive offspring of type 2 diabetic parents 256
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 256
Modification of arterial baroreflexes by captopril in essential hypertension 256
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 256
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 255
Management of antihypertensive drugs in three European countries 254
Brachial and central blood pressure in HIV-infected subjects 254
Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice 253
Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: Real-world evidence from Italy 253
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 252
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 252
Heart Function and Myocardial Tissue Characterization in Patients with HCV Related Cirrhosis: Diastolic Dysfunction and Cardiac Hypertrophy 251
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 250
Radial artery flow-mediated dilatation in heart failure patients: Effects of pharmacological and nonpharmacological treatment 249
Control of blood pressure by carotid sinus baroreceptors in human beings 249
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 249
Totale 30.631
Categoria #
all - tutte 723.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 723.256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.537 0 0 0 0 0 1.240 1.620 1.318 1.295 1.755 805 1.504
2021/202213.855 817 1.326 1.894 1.169 968 906 796 766 760 894 1.332 2.227
2022/202318.878 2.545 5.581 1.588 1.722 1.179 2.913 156 966 1.257 129 515 327
2023/202416.475 597 752 572 587 2.686 3.829 3.078 479 1.821 305 239 1.530
2024/202539.506 2.448 5.072 1.488 1.676 3.520 938 2.227 1.450 4.218 4.929 3.999 7.541
2025/202643.146 8.860 6.960 7.058 9.392 9.736 1.140 0 0 0 0 0 0
Totale 199.879